Although our understanding of the role of different ILCs subsets and their plasticity in tumor immunity is only just beginning, these studies suggest that the targeting of Aiolos and Ikaros may be a relevant therapeutic tool to regulate the different ILC activities in cancer. Here, CCL27 is linked to neoplasm.